Artal Group’s Twist Bioscience TWST Stock Holding History

Artal Group’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-100,000	Closed	-$2.1M	–	115
2019 Q4	$2.1M	Hold	100,000	–	–	0.08%	93
2019 Q3	$2.39M	Hold	100,000	–	–	0.1%	94
2019 Q2	$2.9M	Sell	100,000 -50,000	-33%	-$1.32M	0.12%	91
2019 Q1	$3.48M	Hold	150,000	–	–	0.14%	86
2018 Q4	$3.46M	Buy	+150,000	New	+$3.32M	0.13%	79

Other funds holding TWST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Artal Group's TWST Position: Q1 2020 in Review

Artal Group sold out of Twist Bioscience (TWST) in Q1 2020, closing a stake of 100,000 shares — an estimated $2.1M sold.

Artal Group first reported a position in TWST in Q4 2018 and held it in 5 quarters. The position peaked at $3.48M in Q1 2019. 118 funds tracked by Wall St. Rank hold TWST as of Q1 2020.

Artal Group reported no remaining Twist Bioscience position as of Q1 2020 after selling out during the quarter.
Artal Group sold 100,000 Twist Bioscience shares in Q1 2020, an estimated $2.1M.
Artal Group first reported a position in Twist Bioscience in Q4 2018 and held it in 5 quarters.
Artal Group's Twist Bioscience position peaked at $3.48M in Q1 2019.
118 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2020.

Based on Artal Group's 13F filing for Q1 2020, filed 14 May 2020.